Results 1 to 10 of about 22,098 (274)

CRISPR/Cas13-Based Anti-RNA Viral Approaches

open access: yes
RNA viruses pose significant threats to global health, causing diseases such as COVID-19, HIV/AIDS, influenza, and dengue. These viruses are characterized by high mutation rates, rapid evolution, and the ability to evade traditional antiviral therapies ...
Toischer, Karl   +13 more
core   +1 more source

Testing multiplexed anti-ASFV CRISPR-Cas9 in reducing African swine fever virus

open access: yesMicrobiology Spectrum
African swine fever (ASF) is a highly fatal viral disease that poses a significant threat to domestic pigs and wild boars globally. In our study, we aimed to explore the potential of a multiplexed CRISPR-Cas system in suppressing ASFV replication and ...
Zezhong Zheng   +14 more
doaj   +1 more source

CRISPRoffT: Comprehensive Database of CRISPR/Cas Off-Targets

open access: yes
The CRISPR (clustered regularly interspaced short palindromic repeats)/Cas (CRISPR-associated protein) programmable nuclease system continues to evolve, with in vivo therapeutic gene editing increasingly applied in clinical settings.
Zhou, Xiaobo   +6 more
core   +1 more source

Unveiling the invisible genomic dynamics

open access: yesExperimental and Molecular Medicine
CRISPR-based imaging technologies have emerged as powerful tools for visualizing specific genomic loci, providing groundbreaking insights into chromatin structure and dynamics. Here, in this Review, we discuss the development and recent advances in these
Jiwoong Kwon, Yeji Park, Taekjip Ha
doaj   +1 more source

CRISPR and Fanzor in sickle cell disease: current progress and future prospects. [PDF]

open access: yesFront Genome Ed
Alhumoudi AY   +7 more
europepmc   +1 more source

CasCADE: Cas<i>-C</i>RISPR Automated Design and Evaluation for targeted gRNA detection assays. [PDF]

open access: yesMicrobiol Spectr
Price C   +7 more
europepmc   +1 more source

Advances in CRISPR Plant Applications. [PDF]

open access: yesInt J Mol Sci
Jing L, Roy D, Kalischuk M.
europepmc   +1 more source

Home - About - Disclaimer - Privacy